Discovering Biomarkers within the Genomic Landscape of Renal Cell CarcinomaSankin A*
Department of Urology, USA
- *Corresponding Author:
- Alexander Sankin, MD MS
Department of Urology
SUNY Downstate Medical Center
Brooklyn, NY, USA
E-mail: [email protected]
Received Date: January 11, 2016; Accepted Date: February 15, 2016; Published Date: February 25, 2016
Citation: Sankin A (2016) Discovering Biomarkers within the Genomic Landscape of Renal Cell Carcinoma. J Kidney 2:115. doi:10.4172/2472-1220.1000115
Copyright: © 2016 Sankin A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recent advances in molecular sequencing technology have led to the discovery of numerous biomarkers in renal cell carcinoma (RCC). These biomarkers have the potential to predict clinical outcomes and aid in clinical management decisions. The following commentary is a review of the preliminary data on some of the most promising genetic biomarker candidates.